Rivista 8.33

Structural Cerebellar Abnormalities and Parkinsonism in Patients with 22q11.2 Deletion Syndrome

Autori: Piervincenzi C, Fanella M, Petsas N, Frascarelli M, Morano A, Accinni T, Di Fabio F, Di Bonaventura C, Berardelli A, Pantano P.

Data: 2022

Ambito di interesse: Neuroimmagini/malattie rare

Rivista: Brain Sci. 2022 Nov 12;12(11):1533

Potrebbero interessarti anche:

Rivista 7.32

Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance.

Autori: Cerulli Irelli E, Barone FA, Mari L, Morano A, Orlando B, Salamone EM, Marchi A, Fanella M, Fattouch J, Placidi F, Giallonardo AT, Izzi F, Di Bonaventura C

Data: 2022

Ambito di interesse: Epilessia

Rivista: Front Neurol. 2022 Mar 10;13:844674

Leggi dettagli

Rivista 3,01

Targeting inflammation to slow or delay functional decline: where are we?

Autori: Corsonello A, Garasto S, Abbatecola AM, Rose G, Passarino G, Mazzei B, Pranno L, Guffanti EE, Bustacchini S, Lattanzio F

Data: 2010

Ambito di interesse: biogerontologia

Rivista: Biogerontology

Leggi dettagli

Rivista 7.19

Switch From Originator to Equivalent Drug in the Era of Generic Antiepileptic Drugs: Study of Keppra Versus Epitiram Clinical Equivalence.

Autori: Fanella M, Morano A, Fattouch J, Albini M, Basili LM, Casciato S, Manfredi M, Giallonardo AT, Di Bonaventura C.

Data: 2017

Ambito di interesse: Epilessia

Rivista: Clin Neuropharmacol. 2017 Oct 2

Leggi dettagli

Structural Cerebellar Abnormalities and Parkinsonism in Patients with 22q11.2 Deletion Syndrome

Potrebbero interessarti anche:

Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance.

Targeting inflammation to slow or delay functional decline: where are we?

Switch From Originator to Equivalent Drug in the Era of Generic Antiepileptic Drugs: Study of Keppra Versus Epitiram Clinical Equivalence.

Cosa fare per